COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...
GSK (GSK) stock is in focus as the U.S. FDA expands authorization for the company's Arexvy RSV vaccine to cover adults 18–49. Read more here.
COVID-19 cases remained relatively steady week-over-week in late August, though data from states showed "very high" viral activity at the end of the month, according to the Centers for Disease Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results